Brinker Capital Investments, LLC Vericel Corp Transaction History
Brinker Capital Investments, LLC
- $10.5 Billion
- Q2 2025
A detailed history of Brinker Capital Investments, LLC transactions in Vericel Corp stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 22,457 shares of VCEL stock, worth $780,380. This represents 0.01% of its overall portfolio holdings.
Number of Shares
22,457
Previous 22,457
-0.0%
Holding current value
$780,380
Previous $955,000
-0.0%
% of portfolio
0.01%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding VCEL
# of Institutions
294Shares Held
54MCall Options Held
35.6KPut Options Held
7.7K-
Black Rock Inc. New York, NY8.06MShares$280 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$124 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.81MShares$97.7 Million3.59% of portfolio
-
Conestoga Capital Advisors, LLC2.46MShares$85.6 Million1.56% of portfolio
-
State Street Corp Boston, MA2.44MShares$84.6 Million0.0% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.64B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...